These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30135439)

  • 1. Reproducibility of antimicrobial test methods.
    Parker AE; Hamilton MA; Goeres DM
    Sci Rep; 2018 Aug; 8(1):12531. PubMed ID: 30135439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing.
    Müsken M; Di Fiore S; Römling U; Häussler S
    Nat Protoc; 2010 Aug; 5(8):1460-9. PubMed ID: 20671729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability and reproducibility of germicide tests: a literature review.
    Tilt N; Hamilton MA
    J AOAC Int; 1999; 82(2):384-9. PubMed ID: 10191545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of three commercially available antibiotic discs.
    Joshi A; Iyer V; Balasubramaniam U; Kagal A; Bharadwaj R
    Indian J Med Microbiol; 2008; 26(2):160-2. PubMed ID: 18445955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa.
    Rodríguez-Sevilla G; Crabbé A; García-Coca M; Aguilera-Correa JJ; Esteban J; Pérez-Jorge C
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruggedness and reproducibility of the MBEC biofilm disinfectant efficacy test.
    Parker AE; Walker DK; Goeres DM; Allan N; Olson ME; Omar A
    J Microbiol Methods; 2014 Jul; 102():55-64. PubMed ID: 24815513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.
    Ceri H; Olson ME; Stremick C; Read RR; Morck D; Buret A
    J Clin Microbiol; 1999 Jun; 37(6):1771-6. PubMed ID: 10325322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?
    Díez-Aguilar M; Martínez-García L; Cantón R; Morosini MI
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1158-61. PubMed ID: 26643341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring antimicrobial susceptibility of Pseudomonas aeruginosa using Poloxamer 407 gel.
    Yamada H; Koike N; Ehara T; Matsumoto T
    J Infect Chemother; 2011 Apr; 17(2):195-9. PubMed ID: 20814713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization.
    Di Bonaventura G; Ricci E; Della Loggia N; Catamo G; Piccolomini R
    J Clin Microbiol; 1998 Mar; 36(3):824-6. PubMed ID: 9508323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 14. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents.
    Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1997; 43(2):137-41. PubMed ID: 9084923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.